Literature DB >> 6482673

Prediction of the relative in vitro sensitivity of 9L rat brain tumor cells to nitrosoureas by the sister chromatid exchange assay.

P J Tofilon, M A Gerosa, M L Rosenblum, W J Bodell, D F Deen.   

Abstract

In an earlier study we showed that there is a good correlation between sister chromatid exchange induction and cell kill in 9L cells treated with certain nitrosoureas. In the study reported here, we treated four 9L cell lines that have different sensitivities to chloroethylnitrosoureas with 1,3-bis (2-chloroethyl)-1-nitrosourea, chlorozotocin, and ethylnitrosourea and determined the number of sister chromatid exchanges induced. Cell lines that were most sensitive to the drugs with respect to cell kill were also most sensitive to induction of sister chromatid exchanges for a given drug, and the assay based on sister chromatid exchange is therefore predictive of the relative sensitivity of these cells to the drugs used.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6482673     DOI: 10.1016/0024-3205(84)90360-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Enhancement of in vitro chemotherapeutic activity by dimethylsulfoxide.

Authors:  P J Tofilon; C M Vines; L Milas
Journal:  Clin Exp Metastasis       Date:  1985 Apr-Jun       Impact factor: 5.150

2.  N-methylformamide-mediated enhancement of in vitro tumor cell chemosensitivity.

Authors:  P J Tofilon; C M Vines; L Milas
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.

Authors:  T Yoshida; K Shimizu; Y Ushio; T Hayakawa; H Mogami; Y Sakamoto
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Response to BCNU of spheroids grown from mixtures of drug-sensitive and drug-resistant cells.

Authors:  P J Tofilon; C M Arundel; D F Deen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.